GLP1R and steatosis: An investigation demonstrated that both live and heat-inactivated Butyricimonas virosa mitigated adverse effects such as weight loss, hyperglycemia, and steatosis—in diseased mice by activating Glucagon-like peptide 1 receptors (GLP-1R) in the liver within an obese mouse model (49).